$5.99
0.152.57%
At close: -
$5.99
0.000.00%
After Hours: Dec 20, 4:00 PM EDT
Comments
Loading...
Fennec Pharmaceuticals (FENC) Forecast
NewsEarningsFennec Pharmaceuticals (FENC) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestFennec Pharmaceuticals (NASDAQ:FENC) Stock Quotes, Forecast and News Summary
Fennec Pharmaceuticals Stock (NASDAQ: FENC) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Fennec Pharmaceuticals (FENC) stock?
You can purchase shares of Fennec Pharmaceuticals (NASDAQ:FENC) through any online brokerage.
Who are Fennec Pharmaceuticals (FENC) competitors?
There are no as such competitors for Fennec Pharmaceuticals.
What is the forecast, or price target, for Fennec Pharmaceuticals (FENC) stock?
Fennec Pharmaceuticals has a consensus price target of $14.33.
What is the current price for Fennec Pharmaceuticals (FENC)?
The stock price for Fennec Pharmaceuticals (NASDAQ: FENC) is $5.99 last updated December 20, 2024 at 4:00 PM EST.
Does Fennec Pharmaceuticals (FENC) pay a dividend?
A quarterly cash dividend of 0.58 per share of Class A Common Stock. The quarterly cash dividend was payable on April 29, 2016 to stockholders of record on April 22, 2016.
When is Fennec Pharmaceuticals (NASDAQ:FENC) reporting earnings?
Fennec Pharmaceuticals’s Q4 earnings are confirmed for Thursday, March 20, 2025.
Is Fennec Pharmaceuticals (FENC) going to split?
There is no upcoming split for Fennec Pharmaceuticals.
What sector and industry does Fennec Pharmaceuticals (FENC) operate in?
Fennec Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.